Perognathus longimembris pacificus isolate PPM17 chromosome 22, ASM2315922v1, whole genome shotgun sequence.
Perognathus longimembris pacificus (Pacific pocket mouse)
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Castorimorpha; Heteromyidae; Perognathinae; Perognathus.
REFSEQ INFORMATION: The reference sequence is identical to\nCM041285.1.\nAssembly name: ASM2315922v1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the San Diego Zoo Wildlife\nAlliance on 2022/04/27. The original whole-genome shotgun project\nhas the accession JALGBO000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: San Diego Zoo Wildlife Alliance\nAssembly Date :: 2021\nAssembly Method :: Peregrine v. JUNE-2020; HiRise v.\n JULY-2020; Juicer v. DECEMBER-2020;\n Juicebox Assembly Tools v. DECEMBER-2020\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 23.0x\nSequencing Technology :: PacBio Sequel\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Perognathus longimembris pacificus\n Annotation Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
ADAM metallopeptidase with thrombospondin type 1 motif 19, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
A disintegrin and metalloproteinase with thrombospondin motifs 19 isoform X2
ADAM metallopeptidase with thrombospondin type 1 motif 19, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
A disintegrin and metalloproteinase with thrombospondin motifs 19 isoform X1
membrane integral NOTCH2 associated receptor 2
COORDINATES: polyA evidence [ECO:0006239]
major intrinsically disordered NOTCH2-binding receptor 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
interferon-inducible GTPase 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
interferon-inducible GTPase 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
interferon-inducible GTPase 1-like isoform X2
interferon-inducible GTPase 1-like, transcript variant X1
interferon-inducible GTPase 1-like isoform X1
dynactin subunit 4, transcript variant X1
dynactin subunit 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 55% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; deleted 2 bases in 2 codons; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ribosomal protein S14, transcript variant X1
ribosomal protein S14, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
HLA class II histocompatibility antigen gamma chain isoform X1
HLA class II histocompatibility antigen gamma chain isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
calcium/calmodulin dependent protein kinase II alpha
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: calcium/calmodulin-dependent protein kinase type II subunit alpha
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 5 bases in 4 codons; deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 6% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 5 bases in 4 codons; deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: sodium-dependent proline transporter
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins
platelet derived growth factor receptor beta
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
platelet-derived growth factor receptor beta
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
macrophage colony-stimulating factor 1 receptor
HMG-box containing 3, transcript variant X3
HMG-box containing 3, transcript variant X4
HMG-box containing 3, transcript variant X2
HMG-box containing 3, transcript variant X1
HMG domain-containing protein 3 isoform X4
HMG domain-containing protein 3 isoform X1
HMG domain-containing protein 3 isoform X2
HMG domain-containing protein 3 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 79% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 8 bases in 7 codons; deleted 5 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 8 bases in 7 codons; deleted 5 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: peroxisome proliferator-activated receptor gamma coactivator 1-beta
Rho guanine nucleotide exchange factor 37
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 82% coverage of the annotated genomic feature by RNAseq alignments
casein kinase 1 alpha 1, transcript variant X1
casein kinase 1 alpha 1, transcript variant X2
casein kinase 1 alpha 1, transcript variant X3
casein kinase 1 alpha 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 9 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
actin filament associated protein 1 like 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
actin filament-associated protein 1-like 1
actin binding LIM protein family member 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
actin binding LIM protein family member 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
actin binding LIM protein family member 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
actin binding LIM protein family member 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
SH3 domain and tetratricopeptide repeats 2, transcript variant X1
SH3 domain and tetratricopeptide repeats 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
SH3 domain and tetratricopeptide repeats 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
SH3 domain and tetratricopeptide repeat-containing protein 2 isoform X1
SH3 domain and tetratricopeptide repeat-containing protein 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 71% coverage of the annotated genomic feature by RNAseq alignments
serine protease inhibitor Kazal-type 7-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
serine protease inhibitor Kazal-type 6-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins
serine protease inhibitor Kazal-type 6-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
serine protease inhibitor Kazal-type 6-like isoform X2
serine protease inhibitor Kazal-type 6-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 30% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 72% coverage of the annotated genomic feature by RNAseq alignments
janus kinase and microtubule interacting protein 2, transcript variant X1
janus kinase and microtubule interacting protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
janus kinase and microtubule-interacting protein 2 isoform X1
janus kinase and microtubule-interacting protein 2 isoform X2
dihydropyrimidinase like 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 mRNAs, 30 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
dihydropyrimidinase-related protein 3 isoform X1
dihydropyrimidinase like 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 mRNAs, 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
dihydropyrimidinase-related protein 3 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
protein phosphatase 2 regulatory subunit Bbeta, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 24 Proteins, and 73% coverage of the annotated genomic feature by RNAseq alignments
protein phosphatase 2 regulatory subunit Bbeta, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 35 Proteins, and 76% coverage of the annotated genomic feature by RNAseq alignments
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform isoform X1
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform isoform X2
protein phosphatase 2 regulatory subunit Bbeta, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 mRNAs, 33 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform isoform X3
transcription elongation regulator 1, transcript variant X4
transcription elongation regulator 1, transcript variant X3
transcription elongation regulator 1, transcript variant X2
transcription elongation regulator 1, transcript variant X1
transcription elongation regulator 1 isoform X4
transcription elongation regulator 1 isoform X3
transcription elongation regulator 1 isoform X2
transcription elongation regulator 1 isoform X1
transcription elongation regulator 1, transcript variant X5
transcription elongation regulator 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
transcription elongation regulator 1 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins
POU domain, class 4, transcription factor 3
RNA binding motif protein 27, transcript variant X5
RNA binding motif protein 27, transcript variant X2
RNA binding motif protein 27, transcript variant X4
RNA binding motif protein 27, transcript variant X3
RNA binding motif protein 27, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 64% coverage of the annotated genomic feature by RNAseq alignments
glutaredoxin and cysteine rich domain containing 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins
glutaredoxin domain-containing cysteine-rich protein 2
PRELI domain containing 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
PRELI domain containing 2, transcript variant X2
PRELI domain containing 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
PRELI domain containing 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 mRNAs, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
PRELI domain-containing protein 2 isoform X3
PRELI domain-containing protein 2 isoform X2
PRELI domain-containing protein 2 isoform X1
28S ribosomal protein S35, mitochondrial-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 58% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: 28S ribosomal protein S35, mitochondrial-like
potassium channel tetramerization domain containing 16
BTB/POZ domain-containing protein KCTD16
COORDINATES: nucleotide motif:Rfam:12.0:RF00561
Yip1 domain family member 5, transcript variant X2
Yip1 domain family member 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA glycine (anticodon UCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
nuclear receptor subfamily 3 group C member 1, transcript variant X3
nuclear receptor subfamily 3 group C member 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
nuclear receptor subfamily 3 group C member 1, transcript variant X1
nuclear receptor subfamily 3 group C member 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 80% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Nedd4 family interacting protein 1, transcript variant X1
Nedd4 family interacting protein 1, transcript variant X2
NEDD4 family-interacting protein 1 isoform X1
NEDD4 family-interacting protein 1 isoform X2
glucosamine-6-phosphate deaminase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 mRNAs, 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
glucosamine-6-phosphate deaminase 1, transcript variant X2
ring finger protein 14, transcript variant X1
ring finger protein 14, transcript variant X2
ring finger protein 14, transcript variant X3
E3 ubiquitin-protein ligase RNF14 isoform X1
E3 ubiquitin-protein ligase RNF14 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3, transcript variant X5
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3, transcript variant X7
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3, transcript variant X2
arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 3 isoform X1
arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 3 isoform X2
arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 3 isoform X3
arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 3 isoform X4
FCH and double SH3 domains 1, transcript variant X1
FCH and double SH3 domains 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
F-BAR and double SH3 domains protein 1 isoform X1
F-BAR and double SH3 domains protein 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
histone deacetylase 3, transcript variant X1
histone deacetylase 3, transcript variant X2
diaphanous related formin 1, transcript variant X2
diaphanous related formin 1, transcript variant X1
protocadherin gamma-C4, transcript variant X17
protocadherin gamma-C4, transcript variant X9
protocadherin gamma-C4, transcript variant X8
protocadherin gamma-C4, transcript variant X11
protocadherin gamma-C4, transcript variant X12
protocadherin gamma-C4, transcript variant X16
protocadherin gamma-C4, transcript variant X7
protocadherin gamma-C4, transcript variant X15
protocadherin gamma-C4, transcript variant X13
protocadherin gamma-C4, transcript variant X6
protocadherin gamma-C4, transcript variant X10
protocadherin gamma-C4, transcript variant X18
protocadherin gamma-C4, transcript variant X5
protocadherin gamma-C4, transcript variant X4
protocadherin gamma-C4, transcript variant X3
protocadherin gamma-C4, transcript variant X2
protocadherin gamma-C4, transcript variant X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 56 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: protocadherin gamma-B2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 62 Proteins, and 39% coverage of the annotated genomic feature by RNAseq alignments
protocadherin gamma-C4, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 60 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 103 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 64 Proteins, and 75% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 77% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: protocadherin gamma-A4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 92 Proteins, and 76% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 67% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 84 Proteins, and 58% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 67% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 86 Proteins, and 57% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 88 Proteins, and 67% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 57% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 40% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 71 Proteins, and 82% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 53% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 90 Proteins, and 76% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 49 Proteins, and 80% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 87 Proteins, and 62% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 84 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 81 Proteins, and 60% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 95 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 86 Proteins, and 81% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 95 Proteins, and 76% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 15% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 95 Proteins, and 54% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: protocadherin gamma-B1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 65 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 56 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 48 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 60% coverage of the annotated genomic feature by RNAseq alignments
TATA-box binding protein associated factor 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
TATA-box binding protein associated factor 7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
transcription initiation factor TFIID subunit 7
mitochondrial ornithine transporter 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 80 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 78 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 80 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 78 Proteins, and 25% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 70% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 51 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 48 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 49 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments
protocadherin beta-2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 44% coverage of the annotated genomic feature by RNAseq alignments
protocadherin beta-2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins
protocadherin alpha-C2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 11 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
protocadherin alpha-C2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 197 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
protocadherin alpha-C2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 196 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00619
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 172 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 189 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 183 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 189 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments
LIM domain transcription factor LMO4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 162 Proteins, and 79% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 45% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 171 Proteins, and 67% coverage of the annotated genomic feature by RNAseq alignments
histidyl-tRNA synthetase 2, mitochondrial
DND microRNA-mediated repression inhibitor 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
NADH:ubiquinone oxidoreductase subunit A2
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2
transmembrane and coiled-coil domains 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
transmembrane and coiled-coil domains 6, transcript variant X4
transmembrane and coiled-coil domains 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
transmembrane and coiled-coil domains 6, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
transmembrane and coiled-coil domain-containing protein 6 isoform X1
transmembrane and coiled-coil domain-containing protein 6 isoform X2
transmembrane and coiled-coil domain-containing protein 6 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 19% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein LOC125340208
probable UDP-sugar transporter protein SLC35A4
SLC35A4 upstream open reading frame protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
amyloid beta precursor protein binding family B member 3, transcript variant X1
amyloid beta precursor protein binding family B member 3, transcript variant X2
amyloid-beta A4 precursor protein-binding family B member 3 isoform X1
amyloid-beta A4 precursor protein-binding family B member 3 isoform X2
steroid receptor RNA activator 1, transcript variant X1
steroid receptor RNA activator 1, transcript variant X2
steroid receptor RNA activator 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 79% coverage of the annotated genomic feature by RNAseq alignments
steroid receptor RNA activator 1 isoform X1
steroid receptor RNA activator 1 isoform X2
steroid receptor RNA activator 1 isoform X3
ankyrin repeat and KH domain containing 1, transcript variant X6
ankyrin repeat and KH domain containing 1, transcript variant X5
ankyrin repeat and KH domain containing 1, transcript variant X3
ankyrin repeat and KH domain containing 1, transcript variant X4
ankyrin repeat and KH domain containing 1, transcript variant X2
ankyrin repeat and KH domain containing 1, transcript variant X1
ankyrin repeat and KH domain containing 1, transcript variant X11
ankyrin repeat and KH domain containing 1, transcript variant X10
ankyrin repeat and KH domain containing 1, transcript variant X9
ankyrin repeat and KH domain-containing protein 1 isoform X11
ankyrin repeat and KH domain-containing protein 1 isoform X6
ankyrin repeat and KH domain-containing protein 1 isoform X5
ankyrin repeat and KH domain-containing protein 1 isoform X10
ankyrin repeat and KH domain-containing protein 1 isoform X3
ankyrin repeat and KH domain-containing protein 1 isoform X9
ankyrin repeat and KH domain-containing protein 1 isoform X4
ankyrin repeat and KH domain-containing protein 1 isoform X2
ankyrin repeat and KH domain-containing protein 1 isoform X1
ankyrin repeat and KH domain containing 1, transcript variant X8
ankyrin repeat and KH domain containing 1, transcript variant X15
ankyrin repeat and KH domain containing 1, transcript variant X7
ankyrin repeat and KH domain-containing protein 1 isoform X8
ankyrin repeat and KH domain-containing protein 1 isoform X14
ankyrin repeat and KH domain-containing protein 1 isoform X7
ankyrin repeat and KH domain containing 1, transcript variant X12
ankyrin repeat and KH domain containing 1, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ankyrin repeat and KH domain-containing protein 1 isoform X12
ankyrin repeat and KH domain containing 1, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ankyrin repeat and KH domain-containing protein 1 isoform X13
ankyrin repeat and KH domain containing 1, transcript variant X16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments
ankyrin repeat and KH domain-containing protein 1 isoform X15
COORDINATES: nucleotide motif:Rfam:12.0:RF01210
solute carrier family 4 member 9, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
solute carrier family 4 member 9, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
solute carrier family 4 member 9, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
solute carrier family 4 member 9, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
heparin binding EGF like growth factor, transcript variant X2
heparin binding EGF like growth factor, transcript variant X1
proheparin-binding EGF-like growth factor
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 81% coverage of the annotated genomic feature by RNAseq alignments
purine rich element binding protein A, transcript variant X2
purine rich element binding protein A, transcript variant X1
purine rich element binding protein A, transcript variant X3
transcriptional activator protein Pur-alpha
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 69% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 71% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 68% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 67% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 68% coverage of the annotated genomic feature by RNAseq alignments
pro-neuregulin-2, membrane-bound isoform isoform X2
pro-neuregulin-2, membrane-bound isoform isoform X1
pro-neuregulin-2, membrane-bound isoform isoform X3
pro-neuregulin-2, membrane-bound isoform isoform X4
pro-neuregulin-2, membrane-bound isoform isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins
CXXC finger protein 5, transcript variant X2
CXXC finger protein 5, transcript variant X1
stimulator of interferon response cGAMP interactor 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
stimulator of interferon genes protein isoform X1
stimulator of interferon response cGAMP interactor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
stimulator of interferon genes protein isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
endothelial cell surface expressed chemotaxis and apoptosis regulator, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
endothelial cell surface expressed chemotaxis and apoptosis regulator, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
endothelial cell-specific chemotaxis regulator isoform X1
endothelial cell-specific chemotaxis regulator isoform X2
DnaJ heat shock protein family (Hsp40) member C18
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
spermatogenesis associated 24, transcript variant X1
spermatogenesis associated 24, transcript variant X2
spermatogenesis-associated protein 24 isoform X1
spermatogenesis-associated protein 24 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
marginal zone B and B1 cell specific protein
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
LOW QUALITY PROTEIN: marginal zone B- and B1-cell-specific protein
poly(A) binding protein interacting protein 2, transcript variant X1
poly(A) binding protein interacting protein 2, transcript variant X2
polyadenylate-binding protein-interacting protein 2
COORDINATES: nucleotide motif:Rfam:12.0:RF00090
SIL1 nucleotide exchange factor, transcript variant X2
SIL1 nucleotide exchange factor, transcript variant X3
SIL1 nucleotide exchange factor, transcript variant X1
nucleotide exchange factor SIL1 isoform X1
nucleotide exchange factor SIL1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
leucine rich repeat transmembrane neuronal 2
leucine-rich repeat transmembrane neuronal protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 34% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 47% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
heat shock protein family A (Hsp70) member 9
COORDINATES: nucleotide motif:Rfam:12.0:RF00154
eukaryotic translation termination factor 1
eukaryotic peptide chain release factor subunit 1
receptor accessory protein 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
receptor accessory protein 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
receptor accessory protein 2, transcript variant X2
receptor accessory protein 2, transcript variant X5
receptor accessory protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
receptor expression-enhancing protein 2 isoform X2
receptor expression-enhancing protein 2 isoform X5
receptor expression-enhancing protein 2 isoform X1
receptor expression-enhancing protein 2 isoform X4
receptor expression-enhancing protein 2 isoform X3
lysine demethylase 3B, transcript variant X4
lysine demethylase 3B, transcript variant X3
lysine demethylase 3B, transcript variant X2
lysine demethylase 3B, transcript variant X1
lysine-specific demethylase 3B isoform X4
lysine-specific demethylase 3B isoform X3
lysine-specific demethylase 3B isoform X2
lysine-specific demethylase 3B isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
family with sequence similarity 53 member C, transcript variant X2
family with sequence similarity 53 member C, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 12% coverage of the annotated genomic feature by RNAseq alignments
cell division cycle 25C, transcript variant X1
cell division cycle 25C, transcript variant X5
cell division cycle 25C, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cell division cycle 25C, transcript variant X2
cell division cycle 25C, transcript variant X4
M-phase inducer phosphatase 3 isoform X1
M-phase inducer phosphatase 3 isoform X3
M-phase inducer phosphatase 3 isoform X2
M-phase inducer phosphatase 3 isoform X4
M-phase inducer phosphatase 3 isoform X5
angiogenic factor with G-patch and FHA domains 1
angiogenic factor with G patch and FHA domains 1
zinc finger BED-type containing 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
zinc finger BED-type containing 3, transcript variant X4
zinc finger BED-type containing 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
zinc finger BED-type containing 3, transcript variant X1
zinc finger BED-type containing 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
zinc finger BED domain-containing protein 3
COORDINATES: nucleotide motif:Rfam:12.0:RF01234
phosphodiesterase 8B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 mRNAs, 14 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
phosphodiesterase 8B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 6 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
phosphodiesterase 8B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 14 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
phosphodiesterase 8B, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 5 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
high affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B isoform X1
high affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B isoform X3
high affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B isoform X2
high affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B isoform X4
phosphodiesterase 8B, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
high affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B isoform X5
WD repeat domain 41, transcript variant X2
WD repeat domain 41, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
WD repeat-containing protein 41 isoform X1
WD repeat-containing protein 41 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 16% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 6 Proteins
adaptor related protein complex 3 subunit beta 1
secretory carrier-associated membrane protein 1
LHFPL tetraspan subfamily member 2, transcript variant X2
LHFPL tetraspan subfamily member 2, transcript variant X1
LHFPL tetraspan subfamily member 2, transcript variant X3
LHFPL tetraspan subfamily member 2 protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
dimethylglycine dehydrogenase, mitochondrial
betaine--homocysteine S-methyltransferase 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 mRNAs, 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
junction mediating and regulatory protein, p53 cofactor
junction-mediating and -regulatory protein
terminal nucleotidyltransferase 2, transcript variant X4
terminal nucleotidyltransferase 2, transcript variant X3
terminal nucleotidyltransferase 2, transcript variant X2
terminal nucleotidyltransferase 2, transcript variant X5
terminal nucleotidyltransferase 2, transcript variant X1
terminal nucleotidyltransferase 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 75% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: nucleotide motif:Rfam:12.0:RF00001
zinc finger FYVE-type containing 16, transcript variant X2
zinc finger FYVE-type containing 16, transcript variant X1
zinc finger FYVE-type containing 16, transcript variant X4
zinc finger FYVE-type containing 16, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
zinc finger FYVE domain-containing protein 16 isoform X1
zinc finger FYVE domain-containing protein 16 isoform X3
zinc finger FYVE domain-containing protein 16 isoform X2
family with sequence similarity 151 member B, transcript variant X3
family with sequence similarity 151 member B, transcript variant X1
family with sequence similarity 151 member B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
ankyrin repeat domain-containing protein 34B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
DNA mismatch repair protein Msh3 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
DNA mismatch repair protein Msh3 isoform X1
Ras protein specific guanine nucleotide releasing factor 2, transcript variant X1
Ras protein specific guanine nucleotide releasing factor 2, transcript variant X2
Ras protein specific guanine nucleotide releasing factor 2, transcript variant X3
ras-specific guanine nucleotide-releasing factor 2 isoform X1
ras-specific guanine nucleotide-releasing factor 2 isoform X2
ras-specific guanine nucleotide-releasing factor 2 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 30% coverage of the annotated genomic feature by RNAseq alignments
zinc finger CCHC-type containing 9, transcript variant X2
zinc finger CCHC-type containing 9, transcript variant X1
zinc finger CCHC domain-containing protein 9
acyl-CoA thioesterase 12, transcript variant X2
acyl-CoA thioesterase 12, transcript variant X1
acyl-CoA thioesterase 12, transcript variant X3
acetyl-coenzyme A thioesterase isoform X1
acetyl-coenzyme A thioesterase isoform X2
single stranded DNA binding protein 2, transcript variant X3
single stranded DNA binding protein 2, transcript variant X1
single stranded DNA binding protein 2, transcript variant X2
single-stranded DNA-binding protein 2 isoform X3
single-stranded DNA-binding protein 2 isoform X1
single-stranded DNA-binding protein 2 isoform X2
autophagy related 10, transcript variant X1
autophagy related 10, transcript variant X2
ubiquitin-like-conjugating enzyme ATG10 isoform X1
ubiquitin-like-conjugating enzyme ATG10 isoform X2
V-type proton ATPase subunit S1-like protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 80% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins
COORDINATES: nucleotide motif:Rfam:12.0:RF01233
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
hyaluronan and proteoglycan link protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
EGF like repeats and discoidin domains 3, transcript variant X2
EGF like repeats and discoidin domains 3, transcript variant X1
EGF-like repeat and discoidin I-like domain-containing protein 3 isoform X2
EGF-like repeat and discoidin I-like domain-containing protein 3 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 61% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: nucleotide motif:Rfam:12.0:RF00015
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 76% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 5 Proteins, and 70% coverage of the annotated genomic feature by RNAseq alignments
cytochrome c oxidase subunit 7C, mitochondrial, transcript variant X2
cytochrome c oxidase subunit 7C, mitochondrial, transcript variant X1
cytochrome c oxidase subunit 7C, mitochondrial
COORDINATES: nucleotide motif:Rfam:12.0:RF00341
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 18% coverage of the annotated genomic feature by RNAseq alignments
transmembrane protein 161B, transcript variant X1
transmembrane protein 161B, transcript variant X5
transmembrane protein 161B, transcript variant X3
transmembrane protein 161B, transcript variant X4
transmembrane protein 161B, transcript variant X2
transmembrane protein 161B, transcript variant X6
transmembrane protein 161B, transcript variant X7
COORDINATES: nucleotide motif:Rfam:12.0:RF00432
myocyte enhancer factor 2C, transcript variant X14
myocyte enhancer factor 2C, transcript variant X2
myocyte enhancer factor 2C, transcript variant X13
myocyte enhancer factor 2C, transcript variant X11
myocyte enhancer factor 2C, transcript variant X1
myocyte enhancer factor 2C, transcript variant X12
myocyte enhancer factor 2C, transcript variant X7
myocyte enhancer factor 2C, transcript variant X8
myocyte enhancer factor 2C, transcript variant X6
myocyte enhancer factor 2C, transcript variant X4
myocyte enhancer factor 2C, transcript variant X5
myocyte enhancer factor 2C, transcript variant X3
myocyte enhancer factor 2C, transcript variant X10
myocyte enhancer factor 2C, transcript variant X9
myocyte-specific enhancer factor 2C isoform X4
myocyte-specific enhancer factor 2C isoform X2
myocyte-specific enhancer factor 2C isoform X3
myocyte-specific enhancer factor 2C isoform X1
myocyte-specific enhancer factor 2C isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 68% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 69% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 43% coverage of the annotated genomic feature by RNAseq alignments
arrestin domain containing 3, transcript variant X2
arrestin domain containing 3, transcript variant X1
arrestin domain-containing protein 3 isoform X1
arrestin domain containing 3, transcript variant X3
arrestin domain containing 3, transcript variant X4
arrestin domain-containing protein 3 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 41% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 78% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 37% coverage of the annotated genomic feature by RNAseq alignments
methylthioribulose-1-phosphate dehydratase-like
lysM and putative peptidoglycan-binding domain-containing protein 3
DNA-directed RNA polymerase III subunit RPC7
metallo-beta-lactamase domain containing 2, transcript variant X1
metallo-beta-lactamase domain containing 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 11% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 13% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: nucleotide motif:Rfam:12.0:RF00004
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins
COORDINATES: nucleotide motif:Rfam:12.0:RF00155
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 28% coverage of the annotated genomic feature by RNAseq alignments
nuclear receptor subfamily 2 group F member 1, transcript variant X1
nuclear receptor subfamily 2 group F member 1, transcript variant X2
family with sequence similarity 172 member A, transcript variant X2
cotranscriptional regulator FAM172A isoform X2
family with sequence similarity 172 member A, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
cotranscriptional regulator FAM172A isoform X5
family with sequence similarity 172 member A, transcript variant X6
cotranscriptional regulator FAM172A isoform X6
family with sequence similarity 172 member A, transcript variant X3
family with sequence similarity 172 member A, transcript variant X7
family with sequence similarity 172 member A, transcript variant X1
cotranscriptional regulator FAM172A isoform X7
cotranscriptional regulator FAM172A isoform X1
cotranscriptional regulator FAM172A isoform X3
family with sequence similarity 172 member A, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
cotranscriptional regulator FAM172A isoform X4
KIAA0825 ortholog, transcript variant X2
KIAA0825 ortholog, transcript variant X4
KIAA0825 ortholog, transcript variant X3
KIAA0825 ortholog, transcript variant X1
uncharacterized protein KIAA0825 homolog isoform X3
uncharacterized protein KIAA0825 homolog isoform X2
uncharacterized protein KIAA0825 homolog isoform X1
KIAA0825 ortholog, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
KIAA0825 ortholog, transcript variant X5
uncharacterized protein KIAA0825 homolog isoform X5
uncharacterized protein KIAA0825 homolog isoform X4
KIAA0825 ortholog, transcript variant X7
uncharacterized protein KIAA0825 homolog isoform X6
KIAA0825 ortholog, transcript variant X8
uncharacterized protein KIAA0825 homolog isoform X7
SMC5-SMC6 complex localization factor protein 1
multiple C2 and transmembrane domain containing 1, transcript variant X5
multiple C2 and transmembrane domain containing 1, transcript variant X4
multiple C2 and transmembrane domain containing 1, transcript variant X9
multiple C2 and transmembrane domain containing 1, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
multiple C2 and transmembrane domain containing 1, transcript variant X6
multiple C2 and transmembrane domain containing 1, transcript variant X2
multiple C2 and transmembrane domain containing 1, transcript variant X11
multiple C2 and transmembrane domain containing 1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
multiple C2 and transmembrane domain containing 1, transcript variant X3
multiple C2 and transmembrane domain containing 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
multiple C2 and transmembrane domain containing 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
multiple C2 and transmembrane domain-containing protein 1 isoform X8
multiple C2 and transmembrane domain-containing protein 1 isoform X9
multiple C2 and transmembrane domain-containing protein 1 isoform X5
multiple C2 and transmembrane domain-containing protein 1 isoform X2
multiple C2 and transmembrane domain-containing protein 1 isoform X10
multiple C2 and transmembrane domain-containing protein 1 isoform X7
multiple C2 and transmembrane domain-containing protein 1 isoform X3
multiple C2 and transmembrane domain-containing protein 1 isoform X6
multiple C2 and transmembrane domain-containing protein 1 isoform X1
multiple C2 and transmembrane domain-containing protein 1 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 49% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: nucleotide motif:Rfam:12.0:RF00108
family with sequence similarity 81 member B
arylsulfatase family member K, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
arylsulfatase family member K, transcript variant X2
rho-related BTB domain-containing protein 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 74% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 7% coverage of the annotated genomic feature by RNAseq alignments
Rieske Fe-S domain containing, transcript variant X3
Rieske Fe-S domain containing, transcript variant X7
Rieske Fe-S domain containing, transcript variant X5
Rieske Fe-S domain containing, transcript variant X4
Rieske Fe-S domain containing, transcript variant X6
Rieske Fe-S domain containing, transcript variant X2
Rieske domain-containing protein isoform X2
Rieske Fe-S domain containing, transcript variant X8
Rieske Fe-S domain containing, transcript variant X1
Rieske domain-containing protein isoform X1
Rho related BTB domain containing 3, transcript variant X2
Rho related BTB domain containing 3, transcript variant X1
rho-related BTB domain-containing protein 3 isoform X1
rho-related BTB domain-containing protein 3 isoform X2
elongation factor for RNA polymerase II 2, transcript variant X2
elongation factor for RNA polymerase II 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
RNA polymerase II elongation factor ELL2 isoform X2
RNA polymerase II elongation factor ELL2 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 34% coverage of the annotated genomic feature by RNAseq alignments
proprotein convertase subtilisin/kexin type 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 mRNAs, 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
endoplasmic reticulum aminopeptidase 1, transcript variant X1
endoplasmic reticulum aminopeptidase 1, transcript variant X2
endoplasmic reticulum aminopeptidase 1, transcript variant X3
endoplasmic reticulum aminopeptidase 1, transcript variant X4
endoplasmic reticulum aminopeptidase 1, transcript variant X5
endoplasmic reticulum aminopeptidase 1 isoform X1
endoplasmic reticulum aminopeptidase 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 17% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 mRNAs, 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
limb and CNS expressed 1, transcript variant X2
limb and CNS expressed 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
protein limb expression 1 homolog isoform X2
protein limb expression 1 homolog isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 37% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 51 Proteins, and 6% coverage of the annotated genomic feature by RNAseq alignments
repulsive guidance molecule BMP co-receptor b
chromodomain helicase DNA binding protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
chromodomain-helicase-DNA-binding protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: nucleotide motif:Rfam:12.0:RF00568
family with sequence similarity 174 member A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
family with sequence similarity 174 member A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 39% coverage of the annotated genomic feature by RNAseq alignments
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4
CMP-N-acetylneuraminate-poly-alpha-2, 8-sialyltransferase
cytochrome b-c1 complex subunit 2, mitochondrial-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: cytochrome b-c1 complex subunit 2, mitochondrial-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 44% coverage of the annotated genomic feature by RNAseq alignments
solute carrier organic anion transporter family member 4C1
solute carrier organic anion transporter family member 6A1
peptidylglycine alpha-amidating monooxygenase, transcript variant X1
peptidylglycine alpha-amidating monooxygenase, transcript variant X2
peptidylglycine alpha-amidating monooxygenase, transcript variant X3
peptidylglycine alpha-amidating monooxygenase, transcript variant X4
peptidylglycine alpha-amidating monooxygenase, transcript variant X5
peptidylglycine alpha-amidating monooxygenase, transcript variant X6
peptidylglycine alpha-amidating monooxygenase, transcript variant X7
peptidylglycine alpha-amidating monooxygenase, transcript variant X8
peptidyl-glycine alpha-amidating monooxygenase isoform X1
peptidyl-glycine alpha-amidating monooxygenase isoform X2
peptidyl-glycine alpha-amidating monooxygenase isoform X3
peptidyl-glycine alpha-amidating monooxygenase isoform X4
peptidyl-glycine alpha-amidating monooxygenase isoform X5
peptidyl-glycine alpha-amidating monooxygenase isoform X6
peptidyl-glycine alpha-amidating monooxygenase isoform X7
peptidyl-glycine alpha-amidating monooxygenase isoform X8
gypsy retrotransposon integrase 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
gypsy retrotransposon integrase 1, transcript variant X3
gypsy retrotransposon integrase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
gypsy retrotransposon integrase 1, transcript variant X2
gypsy retrotransposon integrase 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
gypsy retrotransposon integrase-like protein 1 isoform X3
gypsy retrotransposon integrase-like protein 1 isoform X2
gypsy retrotransposon integrase-like protein 1 isoform X1
gypsy retrotransposon integrase-like protein 1 isoform X4
diphosphoinositol pentakisphosphate kinase 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
diphosphoinositol pentakisphosphate kinase 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
diphosphoinositol pentakisphosphate kinase 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
diphosphoinositol pentakisphosphate kinase 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
diphosphoinositol pentakisphosphate kinase 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 mRNAs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
diphosphoinositol pentakisphosphate kinase 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
diphosphoinositol pentakisphosphate kinase 2, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
diphosphoinositol pentakisphosphate kinase 2, transcript variant X9
diphosphoinositol pentakisphosphate kinase 2, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
diphosphoinositol pentakisphosphate kinase 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
diphosphoinositol pentakisphosphate kinase 2, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
diphosphoinositol pentakisphosphate kinase 2, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
diphosphoinositol pentakisphosphate kinase 2, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 isoform X1
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 isoform X3
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 isoform X4
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 isoform X6
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 isoform X5
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 isoform X8
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 isoform X9
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 isoform X10
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 isoform X2
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 isoform X7
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 isoform X12
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 isoform X13
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 isoform X11
macrophage immunometabolism regulator, transcript variant X4
macrophage immunometabolism regulator, transcript variant X5
macrophage immunometabolism regulator, transcript variant X1
macrophage immunometabolism regulator, transcript variant X3
macrophage immunometabolism regulator, transcript variant X2
macrophage immunometabolism regulator isoform X3
macrophage immunometabolism regulator isoform X2
macrophage immunometabolism regulator isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 81% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 6% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
F-box and leucine rich repeat protein 17
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 90% coverage of the annotated genomic feature by RNAseq alignments
FER tyrosine kinase, transcript variant X3
FER tyrosine kinase, transcript variant X1
FER tyrosine kinase, transcript variant X2
FER tyrosine kinase, transcript variant X5
FER tyrosine kinase, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
FER tyrosine kinase, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
praja ring finger ubiquitin ligase 2, transcript variant X2
praja ring finger ubiquitin ligase 2, transcript variant X1
E3 ubiquitin-protein ligase Praja-2 isoform X2
E3 ubiquitin-protein ligase Praja-2 isoform X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00438
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
transmembrane protein 232, transcript variant X1
transmembrane protein 232, transcript variant X2
solute carrier family 25 member 46, transcript variant X2
mitochondrial outer membrane protein SLC25A46 isoform X2
solute carrier family 25 member 46, transcript variant X1
mitochondrial outer membrane protein SLC25A46 isoform X1
calcium/calmodulin dependent protein kinase IV
calcium/calmodulin-dependent protein kinase type IV
COORDINATES: nucleotide motif:Rfam:12.0:RF00286
StAR related lipid transfer domain containing 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
StAR related lipid transfer domain containing 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
stAR-related lipid transfer protein 4 isoform X1
stAR-related lipid transfer protein 4 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 16% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 40% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: nucleotide motif:Rfam:12.0:RF00396
erythrocyte membrane protein band 4.1 like 4A
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 6 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
LOW QUALITY PROTEIN: band 4.1-like protein 4A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 29% coverage of the annotated genomic feature by RNAseq alignments
APC regulator of WNT signaling pathway, transcript variant X4
APC regulator of WNT signaling pathway, transcript variant X1
APC regulator of WNT signaling pathway, transcript variant X12
APC regulator of WNT signaling pathway, transcript variant X7
APC regulator of WNT signaling pathway, transcript variant X9
APC regulator of WNT signaling pathway, transcript variant X16
APC regulator of WNT signaling pathway, transcript variant X14
adenomatous polyposis coli protein isoform X1
adenomatous polyposis coli protein isoform X3
adenomatous polyposis coli protein isoform X11
adenomatous polyposis coli protein isoform X13
adenomatous polyposis coli protein isoform X6
adenomatous polyposis coli protein isoform X8
adenomatous polyposis coli protein isoform X15
APC regulator of WNT signaling pathway, transcript variant X3
APC regulator of WNT signaling pathway, transcript variant X2
APC regulator of WNT signaling pathway, transcript variant X5
APC regulator of WNT signaling pathway, transcript variant X13
APC regulator of WNT signaling pathway, transcript variant X15
APC regulator of WNT signaling pathway, transcript variant X8
APC regulator of WNT signaling pathway, transcript variant X10
APC regulator of WNT signaling pathway, transcript variant X17
adenomatous polyposis coli protein isoform X2
adenomatous polyposis coli protein isoform X4
adenomatous polyposis coli protein isoform X12
adenomatous polyposis coli protein isoform X14
adenomatous polyposis coli protein isoform X7
adenomatous polyposis coli protein isoform X9
adenomatous polyposis coli protein isoform X16
APC regulator of WNT signaling pathway, transcript variant X6
adenomatous polyposis coli protein isoform X5
APC regulator of WNT signaling pathway, transcript variant X11
adenomatous polyposis coli protein isoform X10
signal recognition particle 19, transcript variant X1
signal recognition particle 19, transcript variant X2
signal recognition particle 19 kDa protein isoform X1
signal recognition particle 19 kDa protein isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 14% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 8% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: lupus La protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 8% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 8% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 27% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 9% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 18% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125340066, transcript variant X1
uncharacterized LOC125340066, transcript variant X2